{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:08:08Z","timestamp":1789013288354,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-EXPR0013"],"award-info":[{"award-number":["ANR-22-EXPR0013"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-EXPR0009"],"award-info":[{"award-number":["ANR-22-EXPR0009"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yebeh.2026.111193","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:34:53Z","timestamp":1784248493000},"page":"111193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["First-episode psychosis and mood disorder onset in individuals with epilepsy"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-2798","authenticated-orcid":false,"given":"Anton","family":"Iftimovici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6107-0964","authenticated-orcid":false,"given":"Estelle","family":"Pruvost-Robieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Demoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"S\u00e9bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chaumette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-9890","authenticated-orcid":false,"given":"Marie-Odile","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-2254","authenticated-orcid":false,"given":"Martine","family":"Gavaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111193_b0005","unstructured":"National Guideline Centre (UK). Evidence review: Psychological treatments for people with epilepsies: Epilepsies in children, young people and adults: diagnosis and management: Evidence review 16. London: National Institute for Health and Care Excellence (NICE); 2022."},{"key":"10.1016\/j.yebeh.2026.111193_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yebeh.2018.01.034","article-title":"Quality of life and level of burden in primary caregivers of patients with epilepsy: effect of neuropsychiatric comorbidity","volume":"81","author":"Gutierrez-Angel","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0015","article-title":"Psychiatric comorbidities in persons with epilepsy compared with persons without epilepsy: a systematic review and meta-analysis","author":"Kwon","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.111193_b0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209622","article-title":"Multipsychiatric comorbidity in people with epilepsy compared with people without epilepsy: a systematic review and meta-analysis","volume":"103","author":"Kwon","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0025","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201671","article-title":"Mood and anxiety disorders and suicidality in patients with newly diagnosed focal epilepsy: an analysis of a complex comorbidity","volume":"100","author":"Kanner","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/epi.17140","article-title":"ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy","volume":"63","author":"Mula","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111193_b0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/epi4.12455","article-title":"Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force","volume":"6","author":"Gandy","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111193_b0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.23601","article-title":"Epilepsy, suicidality, and psychiatric disorders: a bidirectional association","volume":"72","author":"Hesdorffer","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2026.111193_b0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2026.111193_b0050","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231187194","article-title":"Prevalence and risk factors of anxiety and depression in adult patients with epilepsy: a multicenter survey-based study","volume":"16","author":"Shi","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2026.111193_b0055","doi-asserted-by":"crossref","unstructured":"Kanner AM. Psychiatric Comorbidities in Medication-Resistant Epilepsy. In: Stern JM, Sperling M, Sankar R, editors. Medicat.-Resist. Epilepsy Diagn. Treat., Cambridge: Cambridge University Press; 2020, p. 256\u201368. Doi: 10.1017\/9781316492376.023.","DOI":"10.1017\/9781316492376.023"},{"key":"10.1016\/j.yebeh.2026.111193_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108243","article-title":"Individuals who develop drug-resistant epilepsy within a year after initial diagnosis have higher burden of mental and physical diseases one-year prior to epilepsy diagnosis as compared to those whose seizures were controlled during the same interval","volume":"123","author":"Teneralli","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.110215","article-title":"The association of polytherapy and psychiatric comorbidity in epilepsy","volume":"163","author":"Odhiambo","year":"2025","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/epi4.12958","article-title":"Prevalence and associated factors of psychiatric comorbidities in epilepsy in the Casablanca\u2013Settat region of Morocco: a cross\u2010sectional study","volume":"9","author":"Hajji","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2026.111193_b0075","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jama.2022.3880","article-title":"Antiseizure medications for adults with epilepsy: a review","volume":"327","author":"Kanner","year":"2022","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.yebeh.2026.111193_b0080","article-title":"Comorbidities in newly diagnosed epilepsy: pre-existing health conditions are common and complex across age groups","volume":"138","author":"McIntosh","year":"2023","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2026.111193_b0085","first-page":"41","article-title":"Overlap between epilepsy and neurodevelopmental disorders: insights from clinical and genetic studies","author":"Hitomi Shimizu","year":"2022","journal-title":"Exon Publ"},{"key":"10.1016\/j.yebeh.2026.111193_b0090","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1212\/WNL.0000000000201542","article-title":"Directionality of the association between epilepsy and depression","volume":"100","author":"B\u00f8lling-Ladegaard","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0095","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1528-1167.2011.03268.x","article-title":"Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study","volume":"52","author":"Chang","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111193_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107452","article-title":"Psychosis and schizophrenia among patients with epilepsy: a systematic review and meta-analysis","volume":"207","author":"Thapa","year":"2024","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111193_b0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111193_b0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41592-019-0470-3","article-title":"Moving beyond P values: data analysis with estimation graphics","volume":"16","author":"Ho","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.yebeh.2026.111193_b0115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.yebeh.2018.06.046","article-title":"Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of the localization of the epilepsy","volume":"94","author":"Jansen","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0120","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0200-23.2023","article-title":"Stress and epilepsy: towards understanding of neurobiological mechanisms for better management","volume":"10","author":"Jhaveri","year":"2023","journal-title":"Eneuro"},{"key":"10.1016\/j.yebeh.2026.111193_b0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yebeh.2018.04.015","article-title":"Major depressive disorder in epilepsy clinics: a meta-analysis","volume":"84","author":"Kim","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.seizure.2019.02.014","article-title":"Depression in people with epilepsy in West China: status, risk factors and treatment gap","volume":"66","author":"Li","year":"2019","journal-title":"Seizure - Eur J Epilepsy"},{"key":"10.1016\/j.yebeh.2026.111193_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yebeh.2015.06.042","article-title":"Depression and anxiety are associated with reduced antiepileptic drug adherence in chinese patients","volume":"50","author":"Guo","year":"2015","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2026.111193_b0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2014.05.011","article-title":"The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy","volume":"36","author":"Ettinger","year":"2014","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2026.111193_b0145","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yebeh.2010.12.038","article-title":"Psychiatric and neurodevelopmental disorders in childhood-onset epilepsy","volume":"20","author":"Berg","year":"2011","journal-title":"Epilepsy Behav EB"},{"key":"10.1016\/j.yebeh.2026.111193_b0150","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/nm.4225","article-title":"Developmental timing and critical windows for the treatment of psychiatric disorders","volume":"22","author":"Mar\u00edn","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.yebeh.2026.111193_b0155","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/epi.17651","article-title":"Excitatory\/inhibitory balance in epilepsies and neurodevelopmental disorders: depolarizing \u03b3-aminobutyric acid as a common mechanism","volume":"64","author":"Van Van Hugte","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111193_b0160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/pcn.13300","article-title":"Current findings and perspectives on aberrant neural oscillations in schizophrenia","volume":"75","author":"Hirano","year":"2021","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2026.111193_b0165","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2023-101201","article-title":"Psychiatric comorbidities in epilepsy: population co-occurrence, genetic correlations and causal effects","volume":"37","author":"Ahlqvist","year":"2024","journal-title":"Gen Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111193_b0170","article-title":"Bullying involvement and subtypes of disabilities: who is likely to be affected by what?","author":"Hong","year":"2024","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.yebeh.2026.111193_b0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.yebeh.2009.06.015","article-title":"Are children with epilepsy at greater risk for bullying than their peers?","volume":"15","author":"Hamiwka","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0180","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S2215-0366(15)00223-0","article-title":"Bullying by peers in childhood and effects on psychopathology, suicidality, and criminality in adulthood","volume":"2","author":"Klomek","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.yebeh.2026.111193_b0185","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209500","article-title":"Trends in antiseizure medication initiation, switch, or termination in patients with newly diagnosed epilepsy: a nationwide study","volume":"103","author":"Bolin","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2018.04.012","article-title":"Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice","volume":"84","author":"Josephson","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111193_b0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/epi.17856","article-title":"Effect of drug treatment changes and seizure outcomes on depression and suicidality in adults with drug-resistant focal epilepsy","volume":"65","author":"Mula","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111193_b0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.eplepsyres.2012.08.005","article-title":"Quality of life, anxiety and depression in adult patients after add-on of levetiracetam and conversion to levetiracetam monotherapy","volume":"104","author":"Hagemann","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.111193_b0205","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209821","article-title":"The adverse effects of commonly prescribed antiseizure medications in adults with newly diagnosed focal epilepsy","volume":"103","author":"Barnard","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0210","doi-asserted-by":"crossref","unstructured":"Neligan A, Hauser WA, Sander JW. The epidemiology of the epilepsies. Handb. Clin. Neurol., vol. 107, Elsevier; 2012, p. 113\u201333. Doi: 10.1016\/B978-0-444-52898-8.00006-9.","DOI":"10.1016\/B978-0-444-52898-8.00006-9"},{"key":"10.1016\/j.yebeh.2026.111193_b0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0000000000011839","article-title":"Incidence and prevalence of drug-resistant epilepsy","volume":"96","author":"Sultana","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2026.111193_b0220","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2018.4561","article-title":"Prediction tools for psychiatric adverse effects after levetiracetam prescription","volume":"76","author":"Josephson","year":"2019","journal-title":"JAMA Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026003148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:28:23Z","timestamp":1789010903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S1525505026003148"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111193","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-episode psychosis and mood disorder onset in individuals with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111193"}}